scholarly article | Q13442814 |
P356 | DOI | 10.1002/PATH.1710990106 |
P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpath.1710990106 |
https://onlinelibrary.wiley.com/doi/full/10.1002/path.1710990106 | ||
P698 | PubMed publication ID | 5359222 |
P2093 | author name string | Roy S | |
Wolman L | |||
P2860 | cites work | The use of lead citrate at high pH as an electron-opaque stain in electron microscopy | Q26778439 |
The brain-stem lesions in Parkinsonism | Q37272987 | ||
A study of fixation for electron microscopy | Q42971380 | ||
Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue | Q44740772 | ||
Progressive familial myoclonic epilepsy with Lafora bodies. Electron microscopic and histochemical study of a cerebral biopsy. | Q51218771 | ||
LAFORA'S DISEASE. DISTINCT CLINICO-PATHOLOGIC FORM OF UNVERRICHT'S SYNDROME. | Q51257115 | ||
ULTRASTRUCTURE OF CORPORA AMYLACEA | Q51260584 | ||
ELECTRON MICROSCOPIC OBSERVATIONS ON THE HUMAN SUBSTANTIA NIGRA. | Q51274162 | ||
Concentric hyaline inclusion body formation in mental disease analysis of twenty-seven cases. | Q51294103 | ||
Ultrastructure of Lafora bodies | Q72183170 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Parkinson's disease | Q11085 |
P304 | page(s) | 39-44 | |
P577 | publication date | 1969-09-01 | |
P1433 | published in | Journal of Pathology | Q400296 |
P1476 | title | Ultrastructural observations in Parkinsonism | |
P478 | volume | 99 |
Q48822801 | A comparison of autofluorescence emission spectra of bleached neuromelanin in non-diseased substantia nigra with spectra of other intraneuronal pigments in non-diseased and diseased tissue |
Q36425805 | A new type of inclusion body in human spinal cord |
Q34989985 | A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration |
Q48352469 | An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism |
Q48708845 | An ultrastructural study of the synaptic densities, nematosomes, neurotubules, neurofilaments and of a further three-dimensional filamentous network as disclosed by the E-PTA staining procedure |
Q28472271 | C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging |
Q90240136 | Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase |
Q48620412 | Classic and generalized variants of Pick's disease: A clinicopathological, ultrastructural, and immunocytochemical comparative study |
Q48852737 | Cortical changes in the parkinsonian brain: a contribution to the delineation of "diffuse Lewy body disease". |
Q33894382 | Critical role of truncated α-synuclein and aggregates in Parkinson's disease and incidental Lewy body disease |
Q40095790 | Dense core vesicles around the Lewy body in incidental Parkinson's disease: an electron microscopic study |
Q48299267 | Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies |
Q44802800 | Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. |
Q41863606 | Filaments of Lewy bodies contain insoluble cytoskeletal elements |
Q39503766 | Idiopathic Parkinson's disease and the Lewy body disorders |
Q40137936 | Idiopathic parkinsonism with lewy-type inclusions in cerebral cortex. A case report |
Q44016007 | Immunocytochemical localization of synaptic vesicle-specific protein in lewy body-containing neurons in Parkinson's disease |
Q36492162 | Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders |
Q48738928 | Lewy Bodies of Parkinson's Disease Contain Neurofilament Antigens |
Q34478663 | Lewy bodies |
Q34263455 | Lewy bodies in cerebral cortex, report of three cases |
Q92104903 | Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson's Disease |
Q41663203 | Lipofuscin in the cerebellar cortex of albino rats: An electron microscopic study |
Q47801119 | Loss of native α-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells |
Q44212285 | Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease |
Q47300849 | Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. |
Q67914362 | Neuronal inclusions of Parkinson's disease |
Q58216347 | New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies |
Q24597726 | PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease |
Q50532472 | Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals. |
Q49135439 | Parkinson's disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies |
Q92465171 | Parkinson's disease: proteinopathy or lipidopathy? |
Q69846956 | Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses |
Q55347683 | Parkinsonism-physiology and pharmacology. |
Q34842740 | Presenile dementia with Alzheimer-, Pick- and Lewy-body changes |
Q36319183 | Radiating amyloid fibril formation on the surface of lipid membranes through unit-assembly of oligomeric species of α-synuclein |
Q36333500 | Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients. |
Q51109441 | Ultrastructural studies of the nervous system after mercury intoxication. I. Pathological changes in the nerve cell bodies. |
Q70153354 | Ultrastructural study of corpora amylacea in human thyroid gland |
Q39987734 | Ultrastructure of Lewy bodies in the stellate ganglion |
Q24653247 | alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies |
Search more.